日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma.

通过创新的基于 cVLP 的疫苗靶向 PCSK9,增强了 cVLP-HER2 疫苗在 HER2 阳性乳腺癌临床前模型中的治疗活性

Scalambra Laura, Ruzzi Francesca, Pittino Olga Maria, Semprini Maria Sofia, Cappello Chiara, Angelicola Stefania, Palladini Arianna, Nanni Patrizia, Goksøyr Louise, Fougeroux Cyrielle, Penichet Manuel L, Sander Adam Frederik, Lollini Pier-Luigi

Development of cellular models expressing cynomolgus (Macaca fascicularis) HER2 for the functional evaluation of cross-reactive anti-human HER2 response

构建表达食蟹猴(Macaca fascicularis)HER2的细胞模型,用于功能性评估抗人HER2抗体的交叉反应性。

Cappello, Chiara; Ruzzi, Francesca; Consoli, Julia; Semprini, Maria Sofia; Scalambra, Laura; Pittino, Olga Maria; Angelicola, Stefania; Palladini, Arianna; Thorn, Mette; Nanni, Patrizia; Lollini, Pier-Luigi

Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?

脂筏、小窝和表皮生长因子受体家族:是朋友还是敌人?

Ruzzi, Francesca; Cappello, Chiara; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania; Pittino, Olga Maria; Landuzzi, Lorena; Palladini, Arianna; Nanni, Patrizia; Lollini, Pier-Luigi

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy

用于癌症免疫疗法的病毒样颗粒(VLP)疫苗

Ruzzi, Francesca; Semprini, Maria Sofia; Scalambra, Laura; Palladini, Arianna; Angelicola, Stefania; Cappello, Chiara; Pittino, Olga Maria; Nanni, Patrizia; Lollini, Pier-Luigi

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy

HER酪氨酸激酶家族与横纹肌肉瘤:在发病和靶向治疗中的作用

De Giovanni, Carla; Landuzzi, Lorena; Palladini, Arianna; Nicoletti, Giordano; Nanni, Patrizia; Lollini, Pier-Luigi

IFN-γ and CD38 in Hyperprogressive Cancer Development

IFN-γ 和 CD38 在超进展性癌症发展中的作用

Angelicola, Stefania; Ruzzi, Francesca; Landuzzi, Lorena; Scalambra, Laura; Gelsomino, Francesco; Ardizzoni, Andrea; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna

Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft

HER2阳性原发性乳腺癌患者来源异种移植瘤的早期稳定性及晚期随机肿瘤进展

Landuzzi, Lorena; Palladini, Arianna; Ceccarelli, Claudio; Asioli, Sofia; Nicoletti, Giordano; Giusti, Veronica; Ruzzi, Francesca; Ianzano, Marianna L; Scalambra, Laura; Laranga, Roberta; Balboni, Tania; Arigoni, Maddalena; Olivero, Martina; Calogero, Raffaele A; De Giovanni, Carla; Dall'Ora, Massimiliano; Di Oto, Enrico; Santini, Donatella; Foschini, Maria Pia; Cucchi, Maria Cristina; Zanotti, Simone; Taffurelli, Mario; Nanni, Patrizia; Lollini, Pier-Luigi

Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model

利用TS/A小鼠乳腺癌进行生物特征分析,构建功能精准的实验模型

De Giovanni, Carla; Nicoletti, Giordano; Landuzzi, Lorena; Palladini, Arianna; Lollini, Pier-Luigi; Nanni, Patrizia

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

OX40 与 IL12 工程细胞疫苗同时激活会阻碍 HER2/neu 驱动的乳腺癌发生的免疫预防。

Nanni, Patrizia; De Giovanni, Carla; Burocchi, Alessia; Nicoletti, Giordano; Landuzzi, Lorena; Palladini, Arianna; Ianzano, Marianna Lucia; Arioli, Ivano; Colombo, Mario P; Lollini, Pier-Luigi

Cancer immunoprevention: from mice to early clinical trials

癌症免疫预防:从小鼠到早期临床试验

Palladini, Arianna; Landuzzi, Lorena; Lollini, Pier-Luigi; Nanni, Patrizia